A solution to poor solubility; Chiasma secures $5.1M;

> Poor solubility is a problem for pharmaceuticals, in general. This paper looks at the promise of solid lipid nanoparticles and nanosuspensions to improve bioavailability of poor water-soluble drugs. More here

> Massachusetts-based protein drug delivery company Chiasma secured $5.1 million in equity and rights-based funding. More

> World Drug Delivery Congress 2011 will be held in Singapore on Sept. 5 to 7. Release

> Drug delivery abstract of the week: A novel nested liposome drug delivery vehicle capable of ultrasound triggered release of its payload. Abstract

> Drug delivery patent of the week: Self-assembling nanoparticle drug delivery system. Patent

Suggested Articles

Rutgers scientists have developed an anti-inflammatory drug delivery platform to better treat central nervous system injuries and disease.

Purdue's reformulated OxyContin may stop patients from snorting or injecting the drug, but it doesn't curb abuse overall, an FDA panel determined.

Roche is gearing up to launch an eye implant to make its Lucentis AMD drug easier to use. But the drugmaker has even bigger plans for the device.